| For: | Tibble J, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001; 7(4): 460-465 [PMID: 11819811 DOI: 10.3748/wjg.v7.i4.460] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i4/460.htm |
| Number | Citing Articles |
| 1 |
C. Piras, A. Soggiu, V. Greco, A. Cassinotti, G. Maconi, S. Ardizzone, A. Amoresano, G. Bianchi Porro, L. Bonizzi, P. Roncada. Serum protein profiling of early and advanced stage Crohn's disease. EuPA Open Proteomics 2014; 3 doi: 10.1016/j.euprot.2014.02.010
|
| 2 |
James Turvill, Lisa Rook, Maxine Rawle, Gerry Robins, Simon Smale, Prashant Kant, Anne Phillips. Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease. Frontline Gastroenterology 2017; 8(3) doi: 10.1136/flgastro-2016-100780
|
| 3 |
I. Bjarnason, L. Maiden, K. Takeuchi. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview. Falk Symposium 2005; 144 doi: 10.1007/1-4020-2916-0_24
|
| 4 |
Atakan Yeşil, Ebubekir Şenateş, İbrahim Vedat Bayoğlu, Emrullah Düzgün Erdem, Refi k Demirtunç, Ayşe Oya Kurdaş Övünç. Red Cell Distribution Width: A Novel Marker of Activity in Infl ammatory Bowel Disease. Gut and Liver 2011; 5(4) doi: 10.5009/gnl.2011.5.4.460
|
| 5 |
Masaki Ikemoto, Takuya Kotani, Kohki Okada, Shogo Matsuda, Tohru Takeuchi. A hybrid protein is a functional molecule to reduce the cytokine storm caused by excessively activated macrophages. Immunology & Cell Biology 2025; 103(4) doi: 10.1111/imcb.70000
|
| 6 |
|
| 7 |
J.P. Gisbert, A.G. McNicholl. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Digestive and Liver Disease 2009; 41(1) doi: 10.1016/j.dld.2008.05.008
|
| 8 |
Ricardo A Caicedo, Martha Douglas-Escobar, Nan Li, Josef Neu. Gastroenterology and Nutrition: Neonatology Questions and Controversies. 2008; doi: 10.1016/B978-1-4160-3160-4.10006-9
|
| 9 |
Annette Prohl, Wieland Schroedl, Heidrun Rhode, Petra Reinhold. Acute phase proteins as local biomarkers of respiratory infection in calves. BMC Veterinary Research 2015; 11(1) doi: 10.1186/s12917-015-0485-7
|
| 10 |
Eun Soo Kim. Optimal Usage of Fecal Calprotectin for Intestinal Diseases. The Korean Journal of Medicine 2018; 93(4) doi: 10.3904/kjm.2018.93.4.364
|
| 11 |
Ioannis D. Kostakis, Kyriaki G. Cholidou, Konstantinos Kallianidis, Despina Perrea, Aristidis Antsaklis. The role of calprotectin in obstetrics and gynecology. European Journal of Obstetrics & Gynecology and Reproductive Biology 2010; 151(1) doi: 10.1016/j.ejogrb.2010.03.006
|
| 12 |
Abdullah Glil Alkushi, Sara T. Elazab, Ahmed Abdelfattah-Hassan, Hala Mahfouz, Gamal A. Salem, Nagwa I. Sheraiba, Eman A. A. Mohamed, Mai S. Attia, Eman S. El-Shetry, Ayman A. Saleh, Naser A. ElSawy, Doaa Ibrahim. Multi-Strain-Probiotic-Loaded Nanoparticles Reduced Colon Inflammation and Orchestrated the Expressions of Tight Junction, NLRP3 Inflammasome and Caspase-1 Genes in DSS-Induced Colitis Model. Pharmaceutics 2022; 14(6) doi: 10.3390/pharmaceutics14061183
|
| 13 |
Jost Langhorst, Sigrid Elsenbruch, Julia Koelzer, Andreas Rueffer, Andreas Michalsen, Gustav J Dobos. Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices. The American Journal of Gastroenterology 2008; 103(1) doi: 10.1111/j.1572-0241.2007.01556.x
|
| 14 |
Camilia R. Martin, Ricardo A. Caicedo, W. Allan Walker. Gastroenterology and Nutrition: Neonatology Questions and Controversies. 2012; doi: 10.1016/B978-1-4377-2603-9.00004-1
|
| 15 |
Carmelo Scarpignato, Richard H. Hunt. Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention. Gastroenterology Clinics of North America 2010; 39(3) doi: 10.1016/j.gtc.2010.08.010
|
| 16 |
Kaija-Leena Kolho, Taneli Raivio, Harry Lindahl, Erkki Savilahti. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2006; 41(6) doi: 10.1080/00365520500419623
|
| 17 |
Tara J. Cepon‐Robins, Elizabeth K. Mallott, Isabella C. Recca, Theresa E. Gildner. Exploring biocultural determinants of intestinal health: Do resource access and parasite exposure contribute to intestinal inflammation among a preliminary sample of children in rural Mississippi?. American Journal of Biological Anthropology 2023; 182(4) doi: 10.1002/ajpa.24574
|
| 18 |
T. Bjørkkjær, L. A. Brunborg, G. Arslan, R. A. Lind, J. G. Brun, M. Valen, B. Klementsen, A. Berstad, L. Frøyland. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scandinavian Journal of Gastroenterology 2004; 39(11) doi: 10.1080/00365520410009429
|
| 19 |
Britta Noebauer, Lejla Ramic, Andrea Konstantin, Christina Zachbauer, Elisa Einwallner. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting. Biochemia Medica 2017; 27(3) doi: 10.11613/BM.2017.030710
|
| 20 |
Susanta Lahiri, Moumita Maiti, Kaustab Ghosh. Production and separation of 111In: an important radionuclide in life sciences: a mini review. Journal of Radioanalytical and Nuclear Chemistry 2013; 297(3) doi: 10.1007/s10967-012-2344-3
|
| 21 |
N Laforgia, ME Baldassarre, G Pontrelli, F Indrio, MA Altomare, G Di Bitonto, A Mautone. Calprotectin levels in meconium. Acta Paediatrica 2003; 92(4) doi: 10.1111/j.1651-2227.2003.tb00579.x
|
| 22 |
Roberta Caccaro, Renata D’Incá, Giacomo Carlo Sturniolo. Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease. Expert Review of Clinical Immunology 2010; 6(4) doi: 10.1586/eci.10.26
|
| 23 |
M. Schaufelberger, I. Ekman, E. Björnsson, E. Kalaitzakis, T. Ekman. Intestinal Paracellular Permeability is not Affected in Chronic Congestive Heart Failure. European Journal of Heart Failure 2007; 9(6-7) doi: 10.1016/j.ejheart.2007.02.005
|
| 24 |
Iftikhar Ahmed, Faisal Fayyaz, Moneeb Nasir, Zafar Niaz, Manuele Furnari, Lorna Perry. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease – a review. Scandinavian Journal of Gastroenterology 2016; 51(4) doi: 10.3109/00365521.2015.1105286
|
| 25 |
Yunus H Polat, Başak Çakal, Salim Tece, Ilhami Yuksel. Red cell distribution width as a biomarker of disease activity in ulcerative colitis and Crohn’s disease. World Journal of Gastroenterology 2026; 32(38): 121569 doi: 10.3748/wjg.121569
|
| 26 |
|
| 27 |
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 2016; 51(5) doi: 10.1007/s00535-016-1182-4
|
| 28 |
Heriberto Rodriguez, Jan S. Suchodolski, Nora Berghoff, Jörg M. Steiner. Development and analytic validation of a gas chromatography–mass spectrometry method for the measurement of sugar probes in canine serum. American Journal of Veterinary Research 2009; 70(3) doi: 10.2460/ajvr.70.3.320
|
| 29 |
Tawfik El-Raouf. Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis. Archives of Clinical Gastroenterology 2017; doi: 10.17352/2455-2283.000030
|
| 30 |
I. Bjarnason, K. Takeuchi, A. Bjarnason, S. N. Adler, K. Teahon. The G.U.T. of gut. Scandinavian Journal of Gastroenterology 2004; 39(9) doi: 10.1080/00365520410003326
|
| 31 |
Christine Prell, Dorothea Nagel, Folke Freudenberg, Andrea Schwarzer, Sibylle Koletzko. Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study. BMJ Open 2014; 4(5) doi: 10.1136/bmjopen-2013-004558
|
| 32 |
Monika Pruenster, Angela R. M. Kurz, Kyoung-Jin Chung, Xiao Cao-Ehlker, Stephanie Bieber, Claudia F. Nussbaum, Susanne Bierschenk, Tanja K. Eggersmann, Ina Rohwedder, Kristina Heinig, Roland Immler, Markus Moser, Uwe Koedel, Sandra Gran, Rodger P. McEver, Dietmar Vestweber, Admar Verschoor, Tomas Leanderson, Triantafyllos Chavakis, Johannes Roth, Thomas Vogl, Markus Sperandio. Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion. Nature Communications 2015; 6(1) doi: 10.1038/ncomms7915
|
| 33 |
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
|
| 34 |
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(3) doi: 10.1002/ibd.21402
|
| 35 |
Jan M Ehrchen, Cord Sunderkötter, Dirk Foell, Thomas Vogl, Johannes Roth. The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology 2009; 86(3) doi: 10.1189/jlb.1008647
|
| 36 |
G. M. Damen, E. E. S. Nieuwenhuis. Niet-invasieve markers bij inflammatoire darmziekten op de kinderleeftijd. Tijdschrift voor kindergeneeskunde 2005; 73(1) doi: 10.1007/BF03061588
|
| 37 |
Adil Omer Karakus, Ethem Mutlu Temizel, Duygu Udum. Determination of the relationships between serum amyloid A, serum calprotectin and fecal calprotectin in healthy and infectious diarrheic calves and their diagnostic significances as inflammatory markers. Research in Veterinary Science 2023; 164 doi: 10.1016/j.rvsc.2023.105041
|
| 38 |
D. R. van Langenberg, R. B. Gearry, H‐L. Wong, M. Ward, P. R. Gibson. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Internal Medicine Journal 2010; 40(12) doi: 10.1111/j.1445-5994.2009.02102.x
|
| 39 |
Haojie Wang, Rongrong Shao, Sa Wu, Yichen Zhu, Zijun Zhang, Mengting Cui, Manman Xiang, Shanshan Li, Fangtian Fan, Xian Li, Yu Tao. The value of platelet-associated parameters as biomarkers in evaluating the disease activity of inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04603-0
|
| 40 |
Serkan Torun, Bilge Demirel Tunc, Burak Suvak, Hakan Yildiz, Adnan Tas, Abdurrahim Sayilir, Yasemin Ozin Ozderin, Yavuz Beyazit, Ertugrul Kayacetin. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity. Clinics and Research in Hepatology and Gastroenterology 2012; 36(5) doi: 10.1016/j.clinre.2012.06.004
|
| 41 |
Tarang Taghvaei, Iradj Maleki, Farshad Nagshvar, Hafez Fakheri, Vahid Hosseini, Seyed Mohammad Valizadeh, Hassan Neishaboori. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis. Internal and Emergency Medicine 2015; 10(3) doi: 10.1007/s11739-014-1144-x
|
| 42 |
F Costa, M G Mumolo, L Ceccarelli, M Bellini, M R Romano, C Sterpi, A Ricchiuti, S Marchi, M Bottai. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut 2005; 54(3) doi: 10.1136/gut.2004.043406
|
| 43 |
Malgorzata Krzystek-Korpacka, Katarzyna Neubauer, Malgorzata Matusiewicz. Circulating midkine in Crohnʼs disease: Clinical implications. Inflammatory Bowel Diseases 2010; 16(2) doi: 10.1002/ibd.21011
|
| 44 |
Emily L. O'Reilly, Anita Horvatić, Josipa Kuleš, Andrea Gelemanović, Vladimir Mrljak, Yixin Huang, Nicola Brady, Christopher C. Chadwick, P. David Eckersall, Alison Ridyard. Faecal proteomics in the identification of biomarkers to differentiate canine chronic enteropathies. Journal of Proteomics 2022; 254 doi: 10.1016/j.jprot.2021.104452
|
| 45 |
Jacopo Gervasoni, Arcangelo Schiattarella, Valentina Giorgio, Aniello Primiano, Consuelo Russo, Valentina Tesori, Franco Scaldaferri, Andrea Urbani, Cecilia Zuppi, Silvia Persichilli. Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome. Disease Markers 2016; 2016 doi: 10.1155/2016/5340386
|
| 46 |
Shabana F. Pasha, Jonathan A. Leighton. Inflammatory Bowel Disease. 2011; doi: 10.1007/978-1-60327-433-3_15
|
| 47 |
L. Amati, M.E. Passeri, F. Selicato, M.L. Mastronardi, A. Penna, E. Jirillo, V. Covelli. New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease. Immunopharmacology and Immunotoxicology 2006; 28(4) doi: 10.1080/08923970601067326
|
| 48 |
Katarzyna Klimczak, Liliana Lykowska-Szuber, Piotr Eder, Iwona Krela-Kazmierczak, Kamila Stawczyk-Eder, Aleksandra Szymczak, Michal Michalak, Adam Studniarek, Krzysztof Linke. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity. European Journal of Internal Medicine 2015; 26(8) doi: 10.1016/j.ejim.2015.06.015
|
| 49 |
MATTHIAS BRUEWER, STANISLAV SAMARIN, ASMA NUSRAT. Inflammatory Bowel Disease and the Apical Junctional Complex. Annals of the New York Academy of Sciences 2006; 1072(1) doi: 10.1196/annals.1326.017
|
| 50 |
Scott E Evans, Michael J Tuvim, Jiexin Zhang, Derek T Larson, Cesar D García, Sylvia Martinez Pro, Kevin R Coombes, Burton F Dickey. Host lung gene expression patterns predict infectious etiology in a mouse model of pneumonia. Respiratory Research 2010; 11(1) doi: 10.1186/1465-9921-11-101
|
| 51 |
Hans J. Vogel. Lactoferrin, a bird’s eye view. Biochemistry and Cell Biology 2012; 90(3) doi: 10.1139/o2012-016
|
| 52 |
Malgorzata Krzystek-Korpacka, Katarzyna Neubauer, Malgorzata Matusiewicz. Clinical relevance of circulating midkine in ulcerative colitis. Clinical Chemistry and Laboratory Medicine 2009; 47(9) doi: 10.1515/CCLM.2009.248
|
| 53 |
Roberta Caccaro, Imerio Angriman, Renata D’Incà. Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. World Journal of Gastrointestinal Surgery 2016; 8(3): 193-201 doi: 10.4240/wjgs.v8.i3.193
|
| 54 |
Renata D’Incà, Giulia Sturniolo. Biomarkers in IBD: What to Utilize for the Diagnosis?. Diagnostics 2023; 13(18) doi: 10.3390/diagnostics13182931
|
| 55 |
Francesca Palone, Roberta Vitali, Salvatore Cucchiara, Maria Pierdomenico, Anna Negroni, Marina Aloi, Federica Nuti, Carla Felice, Alessandro Armuzzi, Laura Stronati. Role of HMGB1 as a Suitable Biomarker of Subclinical Intestinal Inflammation and Mucosal Healing in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(8) doi: 10.1097/MIB.0000000000000113
|
| 56 |
|
| 57 |
Ralph S. Lachman. Taybi and Lachman's Radiology of Syndromes, Metabolic Disorders and Skeletal Dysplasias. 2007; doi: 10.1016/B978-0-323-01931-6.50017-7
|
| 58 |
Z Paduchova, Z Durackova. Fecal calprotectin as a promising marker of inflammatory diseases. Bratislava Medical Journal 2009; 110(10) doi: 10.1007/BF03657231
|
| 59 |
Anna Vaiopoulou, Maria Gazouli, George Theodoropoulos, George Zografos. Current Advantages in the Application of Proteomics in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2012; 57(11) doi: 10.1007/s10620-012-2291-4
|
| 60 |
James Turvill. Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy. Frontline Gastroenterology 2014; 5(3) doi: 10.1136/flgastro-2014-100441
|
| 61 |
Jacopo Gervasoni, Aniello Primiano, Cristina Graziani, Franco Scaldaferri, Antonio Gasbarrini, Andrea Urbani, Silvia Persichilli. Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol. Molecules 2018; 23(10) doi: 10.3390/molecules23102705
|
| 62 |
Antônio Kleiton de Sousa, Ana Clara Coêlho da Costa, Lara da Cunha Muniz, Adão Santiago de Sousa Oliveira, Gabriel da Cruz Santos, Rafael da Silva Prudêncio, Nycole Maria Ramos Melo, Danyela Maria Leal Rocha, Francisco Eduardo Canuto Martins, Emerson Bruno Castro Mesquito, João Janilson da Silva Sousa, Viviane Pinheiro Alves de Almeida, Diva de Aguiar Magalhães, Stefany Guimarães Sousa, André Luiz dos Reis Barbosa. Overview of technological and scientific prospecting in the development of a rapid test for inflammatory bowel disease. Cuadernos de Educación y Desarrollo 2026; 18(1) doi: 10.55905/cuadv18n1-018
|
| 63 |
Mirja Mindemark, Anders Larsson. Ruling out IBD: Estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin. Clinical Biochemistry 2012; 45(7-8) doi: 10.1016/j.clinbiochem.2011.10.015
|
| 64 |
Sajjad Moradi, Reza Bagheri, Parsa Amirian, Mahsa Zarpoosh, Neda Cheraghloo, Alexei Wong, Mehdi Zobeiri, Mohammad Hassan Entezari. Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04400-w
|
| 65 |
Óscar Pastor Rojo, Antonio López San Román, Eduardo Albéniz Arbizu, Antonio de la Hera Martínez, Eduardo Ripoll Sevillano, Agustín Albillos Martínez. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(3) doi: 10.1002/ibd.20019
|
| 66 |
Melanie D. Craven, Robert J. Washabau. Comparative pathophysiology and management of protein-losing enteropathy. Journal of Veterinary Internal Medicine 2019; 33(2) doi: 10.1111/jvim.15406
|
| 67 |
D. DESAI, W. A. FAUBION, W. J. SANDBORN. Review article: biological activity markers in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2007; 25(3) doi: 10.1111/j.1365-2036.2006.03184.x
|
| 68 |
Tomoko Kanki, Takashige Kuwabara, Jun Morinaga, Hirotaka Fukami, Shuro Umemoto, Daisuke Fujimoto, Teruhiko Mizumoto, Manabu Hayata, Yutaka Kakizoe, Yuichiro Izumi, Saeko Tajiri, Tetsuya Tajiri, Kenichiro Kitamura, Masashi Mukoyama. The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-01812-x
|
| 69 |
Alberto Repici, Ahmed Hasan, Anna Paola Capra, Sarah Adriana Scuderi, Irene Paterniti, Michela Campolo, Alessio Ardizzone, Emanuela Esposito. Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?. Marine Drugs 2024; 22(8) doi: 10.3390/md22080336
|
| 70 |
Şeyma Şumnu, Özgür Mehtap, Sinan Mersin, Tayfur Toptaş, Gözde Görür, Ayfer Gedük, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün, Emel Merve Yenihayat, Hayrunnisa Albayrak, Meral Uluköylü Mengüç, Pınar Tarkun, Abdullah Hacıhanifioğlu. Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma. International Journal of Laboratory Hematology 2021; 43(4) doi: 10.1111/ijlh.13559
|
| 71 |
Anastasios Koulaouzidis, Sarah Douglas, Marie A. Rogers, Ian D. Arnott, John N. Plevris. Fecal calprotectin: A selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scandinavian Journal of Gastroenterology 2011; 46(5) doi: 10.3109/00365521.2011.551835
|
| 72 |
Javier P. Gisbert, Adrian G. McNicholl, Fernando Gomollon. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflammatory Bowel Diseases 2009; 15(11) doi: 10.1002/ibd.20920
|
| 73 |
Yuan Zhao, Wanting Qi, Can Huang, Yangzhong Zhou, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Jiuliang Zhao. Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome. Rheumatology and Therapy 2023; 10(6) doi: 10.1007/s40744-023-00610-9
|
| 74 |
Takuya Kotani, Masaki Ikemoto, Shogo Matsuda, Ryota Masutani, Tohru Takeuchi. Human MIKO-1, a Hybrid Protein That Regulates Macrophage Function, Suppresses Lung Fibrosis in a Mouse Model of Bleomycin-Induced Interstitial Lung Disease. International Journal of Molecular Sciences 2022; 23(17) doi: 10.3390/ijms23179669
|
| 75 |
Antje Ballauff, Tobias G. Wenzl, Ralf Bialek, Heiko Witt, Hassan Y. Naim. Pädiatrische Gastroenterologie, Hepatologie und Ernährung. 2013; doi: 10.1007/978-3-642-24710-1_3
|
| 76 |
Tara J. Cepon‐Robins, Theresa E. Gildner, Joshua Schrock, Geeta Eick, Ali Bedbury, Melissa A. Liebert, Samuel S. Urlacher, Felicia C. Madimenos, Christopher J. Harrington, Dorsa Amir, Richard G. Bribiescas, Lawrence S. Sugiyama, James J. Snodgrass. Soil‐transmitted helminth infection and intestinal inflammation among the Shuar of Amazonian Ecuador. American Journal of Physical Anthropology 2019; 170(1) doi: 10.1002/ajpa.23897
|
| 77 |
Zhi-Zheng Ge, Yun-Biao Hu, Shu-Dong Xiao. Capsule endoscopy in diagnosis of small bowel Crohn’s disease. World Journal of Gastroenterology 2004; 10(9): 1349-1352 doi: 10.3748/wjg.v10.i9.1349
|
| 78 |
Basak Cakal, Ayla Gokmen Akoz, Yucel Ustundag, Mesut Yalinkilic, Aysel Ulker, Handan Ankarali. Red Cell Distribution Width for Assessment of Activity of Inflammatory Bowel Disease. Digestive Diseases and Sciences 2009; 54(4) doi: 10.1007/s10620-008-0436-2
|
| 79 |
Monika Pruenster, Thomas Vogl, Johannes Roth, Markus Sperandio. S100A8/A9: From basic science to clinical application. Pharmacology & Therapeutics 2016; 167 doi: 10.1016/j.pharmthera.2016.07.015
|
| 80 |
N. V. Filipenko. NONINVASIVE DIAGNOSIS OF COLORECTAL CANCER AND ULCERATIVE COLITIS BASED ON THE COMBINED USE OF FECAL LACTOFERRIN AND IMMUNOCHEMICAL HEMOCCULT TEST. Health and Ecology Issues 2011; (1) doi: 10.51523/2708-6011.2011-8-1-28
|
| 81 |
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Diogo Branquinho, Luís Correia, Samuel Fernandes, Marília Cravo, Paulo Caldeira, Helena Tavares de Sousa, Marta Patita, Paula Lago, Jaime Ramos, Joana Afonso, Isabel Redondo, Patrícia Machado, George Philip, Joanne Lopes, Fátima Carneiro. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819869141
|
| 82 |
Kohki Okada, Hiroshi Itoh, Yasuhiko Kamikubo, Souichi Adachi, Masaki Ikemoto. Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role. Inflammation 2018; 41(1) doi: 10.1007/s10753-017-0664-8
|
| 83 |
|
| 84 |
Alexander Hanania, Zhi-Dong Jiang, Casey Smiley, Todd Lasco, Kevin W. Garey, Herbert L. DuPont. Fecal Calprotectin in the Diagnosis of Clostridium difficile Infection. Infectious Diseases in Clinical Practice 2016; 24(1) doi: 10.1097/IPC.0000000000000312
|
| 85 |
Dorota Walkiewicz, Steven L. Werlin, Daryl Fish, Mathew Scanlon, Patrick Hanaway, Subra Kugathasan. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases 2008; 14(5) doi: 10.1002/ibd.20376
|
| 86 |
Ervine Chastine Marind, Fiona McCullough. Gut Health Responses to Nutritional Interventions in Paediatric Crohn’s Disease, Including the Potential Outcomes of Mucosal Barrier Preservation: A Systematic Review. Nutrients 2026; 18(7) doi: 10.3390/nu18071146
|
| 87 |
D S Pardi, W J Sandborn. Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?. Gut 2005; 54(3) doi: 10.1136/gut.2004.048850
|
| 88 |
Michel A. Boivin, Dongmei Ye, John C. Kennedy, Rana Al-Sadi, Chris Shepela, Thomas Y. Ma. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007; 292(2) doi: 10.1152/ajpgi.00252.2006
|
| 89 |
Andrew D. Sutherland, Richard B. Gearry, Frank A. Frizelle. Review of Fecal Biomarkers in Inflammatory Bowel Disease. Diseases of the Colon & Rectum 2008; 51(8) doi: 10.1007/s10350-008-9310-8
|
| 90 |
Irene Di Ceglie, Arjen B. Blom, Robab Davar, Colin Logie, Joost H. A. Martens, Ehsan Habibi, Lisa‐Marie Böttcher, Johannes Roth, Thomas Vogl, Carl S. Goodyear, Peter M. van der Kraan, Peter L. van Lent, Martijn H. van den Bosch. The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK. The FASEB Journal 2019; 33(9) doi: 10.1096/fj.201802691RR
|
| 91 |
Safaa I. Khater, Marwa M. Lotfy, Maher N. Alandiyjany, Leena S. Alqahtani, Asmaa W. Zaglool, Fayez Althobaiti, Tamer Ahmed Ismail, Mohamed Mohamed Soliman, Saydat Saad, Doaa Ibrahim. Therapeutic Potential of Quercetin Loaded Nanoparticles: Novel Insights in Alleviating Colitis in an Experimental DSS Induced Colitis Model. Biomedicines 2022; 10(7) doi: 10.3390/biomedicines10071654
|
| 92 |
Marie-Alice Meuwis, Marianne Fillet, Pierre Geurts, Dominique de Seny, Laurence Lutteri, Jean-Paul Chapelle, Vincent Bours, Louis Wehenkel, Jacques Belaiche, Michel Malaise, Edouard Louis, Marie-Paule Merville. Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology 2007; 73(9) doi: 10.1016/j.bcp.2006.12.019
|
| 93 |
Laszlo Lakatos, Gabor Mester, Zsuzsanna Erdelyi, Mihaly Balogh, Istvan Szipocs, Gyorgy Kamaras, Peter Laszlo Lakatos. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World Journal of Gastroenterology 2004; 10(3): 404-409 doi: 10.3748/wjg.v10.i3.404
|
| 94 |
|
| 95 |
Andy Xavier, Annabelle Cesaro. Impact of Exercise Intensity on Calprotectin Levels in Healthy Volunteers and Patients with Inflammatory Rheumatic Diseases. Life 2021; 11(5) doi: 10.3390/life11050377
|
| 96 |
Kayalvily Jesuratnam-Nielsen, Vibeke B. Løgager, Pia Munkholm, Yousef W. Nielsen, Henrik S. Thomsen. Comparison of a New Magnetic Resonance Imaging Protocol and Magnetic Resonance Follow-Through in Patients with Inflammatory Bowel Disease—A Prospective Pilot Study. Open Journal of Radiology 2015; 5(02) doi: 10.4236/ojrad.2015.52018
|
| 97 |
Kurvi Patwala, Peter De Cruz. Biomarkers in Inflammatory Bowel Diseases. 2019; doi: 10.1007/978-3-030-11446-6_8
|
| 98 |
Jost Langhorst, Sigrid Elsenbruch, Twyla Mueller, Andreas Rueffer, Guenther Spahn, Andreas Michalsen, Gustav J Dobos. Comparison of 4 Neutrophil-Derived Proteins in Feces As Indicators of Disease Activity in Ulcerative Colitis. Inflammatory Bowel Diseases 2005; 11(12) doi: 10.1097/01.MIB.0000187980.08686.18
|
| 99 |
Marzena Komraus, Halina Wos, Sabina Wiecek, Maciej Kajor, Urszula Grzybowska-Chlebowczyk. Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease. Mediators of Inflammation 2012; 2012 doi: 10.1155/2012/608249
|
| 100 |
Athanasios Kostas, Spyros I Siakavellas, Charalambos Kosmidis, Anna Takou, Joanna Nikou, Georgios Maropoulos, John Vlachogiannakos, George V Papatheodoridis, Ioannis Papaconstantinou, Giorgos Bamias. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(41): 7387-7396 doi: 10.3748/wjg.v23.i41.7387
|
| 101 |
Shokoufeh Ahmadipour, Mehri Najafi, Farzaneh Motamed, Parisa Rahmani. Feeding-based treatment of allergic proctocolitis and associated clinical outcomes. Clinical Nutrition ESPEN 2020; 40 doi: 10.1016/j.clnesp.2020.09.013
|
| 102 |
Kohki Okada, Masaki Ikemoto. A New Hybrid Protein Is a Novel Regulator for Experimental Colitis in Rats. Inflammation 2022; 45(1) doi: 10.1007/s10753-021-01537-5
|
| 103 |
J.L. Mendoza, M.T. Abreu. Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique 2009; 33 doi: 10.1016/S0399-8320(09)73151-3
|
| 104 |
Katarzyna Akutko, Barbara Iwańczak. Evaluation of Fecal Calprotectin, Serum C-Reactive Protein, Erythrocyte Sedimentation Rate, Seromucoid and Procalcitonin in the Diagnostics and Monitoring of Crohn’s Disease in Children. Journal of Clinical Medicine 2022; 11(20) doi: 10.3390/jcm11206086
|
| 105 |
Maryam Samsami-kor, Naser Ebrahimi Daryani, Parisa Rezanejad Asl, Azita Hekmatdoost. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Archives of Medical Research 2015; 46(4) doi: 10.1016/j.arcmed.2015.05.005
|
| 106 |
Antonella Russo, Hendrik Schürmann, Matthias Brandt, Katja Scholz, Anna Livia L. Matos, David Grill, Julian Revenstorff, Maximilian Rembrink, Meike von Wulffen, Lena Fischer‐Riepe, Peter J. Hanley, Hans Häcker, Monika Prünster, Francisco Sánchez‐Madrid, Sven Hermann, Luisa Klotz, Volker Gerke, Timo Betz, Thomas Vogl, Johannes Roth. Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes. Advanced Science 2022; 9(36) doi: 10.1002/advs.202201505
|
| 107 |
Peter Townsend, Melissa Fernandes. Pediatric Gastrointestinal and Liver Disease. 2021; doi: 10.1016/B978-0-323-67293-1.00009-8
|
| 108 |
Peter Townsend, Sydney Kuzoian. Pediatric Gastrointestinal and Liver Disease. 2026; doi: 10.1016/B978-0-443-11760-2.00009-4
|
| 109 |
Marco Scarpa, Renata D'Incà, Daniela Basso, Cesare Ruffolo, Lino Polese, Eugenia Bertin, Alessia Luise, Mauro Frego, Mario Plebani, Giacomo C. Sturniolo, Davide F. D'Amico, Imerio Angriman. Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn's Disease. Diseases of the Colon & Rectum 2007; 50(6) doi: 10.1007/s10350-007-0225-6
|
| 110 |
Javier P. Gisbert, Yago González-Lama, José Maté. Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2007; 30(3) doi: 10.1157/13100073
|
| 111 |
George Vaos, Ioannis D. Kostakis, Nick Zavras, Athanasios Chatzemichael. The Role of Calprotectin in Pediatric Disease. BioMed Research International 2013; 2013 doi: 10.1155/2013/542363
|
| 112 |
Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco, José Maté. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflammatory Bowel Diseases 2009; 15(8) doi: 10.1002/ibd.20933
|
| 113 |
Claudia I. Reinders, Daisy Jonkers, Emmelie Å. Jansson, Reinhold W. Stockbrügger, Ellen E. Stobberingh, Per M. Hellström, Jon O. Lundberg. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2007; 42(10) doi: 10.1080/00365520701320505
|
| 114 |
R. González, D. Ceacero-Heras, M. Tena-Garitaonaindia, A. Álvarez-Mercado, R. Gámez-Belmonte, W.J. Chazin, F. Sánchez de Medina, O. Martínez-Augustin. Intestinal inflammation marker calprotectin regulates epithelial intestinal zinc metabolism and proliferation in mouse jejunal organoids. Biomedicine & Pharmacotherapy 2024; 174 doi: 10.1016/j.biopha.2024.116555
|
| 115 |
A. Damms, S. C. Bischoff. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. International Journal of Colorectal Disease 2008; 23(10) doi: 10.1007/s00384-008-0506-0
|
| 116 |
Islaine Martins NOGUEIRA, Sender Jankiel MISZPUTEN, Orlando AMBROGINI Jr., Ricardo ARTIGIANI-NETO, Cláudia Teresa CARVENTE, Maria Ivani ZANON. ASSESSMENT OF THE RESPONSE OF PATIENTS WITH CROHN'S DISEASE TO BIOLOGICAL THERAPY USING NEW NON-INVASIVE MARKERS: lactoferrin and calprotectin. Arquivos de Gastroenterologia 2013; 50(2) doi: 10.1590/S0004-28032013000200022
|
| 117 |
Ying Cao, Yibei Dai, Lingyu Zhang, Danhua Wang, Wen Hu, Qiao Yu, Xuchu Wang, Pan Yu, Weiwei Liu, Ying Ping, Tao Sun, Yiwen Sang, Zhenping Liu, Yan Chen, Zhihua Tao. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin. Journal of Inflammation Research 2021; doi: 10.2147/JIR.S342846
|
| 118 |
A. Diamanti, F. Panetta, M. S. Basso, A. Forgione, F. Colistro, F. Bracci, B. Papadatou, P. Francalanci, F. Torroni, D. Knafelz, F. Fina, M. Castro. Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay. Inflammatory Bowel Diseases 2010; 16(11) doi: 10.1002/ibd.21257
|
| 119 |
Carlos J Aranda, Borja Ocón, María Arredondo‐Amador, María Dolores Suárez, Antonio Zarzuelo, Walter J Chazin, Olga Martínez‐Augustin, Fermín Sánchez de Medina. Calprotectin protects against experimental colonic inflammation in mice. British Journal of Pharmacology 2018; 175(19) doi: 10.1111/bph.14449
|
| 120 |
Kohki Okada, Satoshi Arai, Hiroshi Itoh, Souichi Adachi, Masahiko Hayashida, Hiroshi Nakase, Masaki Ikemoto. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells’ immune functions. Journal of Leukocyte Biology 2016; 100(5) doi: 10.1189/jlb.2A0415-170RRR
|
| 121 |
Stanisław Pieczarkowski, Kinga Kowalska-Duplaga, Przemko Kwinta, Przemysław Tomasik, Andrzej Wędrychowicz, Krzysztof Fyderek. Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/8089217
|
| 122 |
Jost Langhorst, James Boone, Romy Lauche, Andreas Rueffer, Gustav Dobos. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial. Journal of Crohn's and Colitis 2016; 10(7) doi: 10.1093/ecco-jcc/jjw044
|
| 123 |
Shaimaa Mohammed Wtwt, Azhar Omran Althahab. Measurement Concentration of Ficolin-1 and Calprotectin for Serum and Swab in Tonsillitis Infection. Medical Journal of Babylon 2025; 22(3) doi: 10.4103/MJBL.MJBL_344_23
|
| 124 |
Imerio Angriman, Marco Scarpa, Renata D'Incà, Daniela Basso, Cesare Ruffolo, Lino Polese, Giacomo C. Sturniolo, Davide F. D'Amico, Mario Plebani. Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clinica Chimica Acta 2007; 381(1) doi: 10.1016/j.cca.2007.02.025
|
| 125 |
Jean Guibourdenche, Dominique Berrebi, Edith Vuillard, Pascal de Lagausie, Yves Aigrain, Jean-François Oury, Dominique Luton. Biochemical Investigations of Bowel Inflammation in Gastroschisis. Pediatric Research 2006; 60(5) doi: 10.1203/01.pdr.0000242344.22638.94
|
| 126 |
Xiao-Hua Jiang, Ning Li, Jie-Shou Li. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World Journal of Gastroenterology 2003; 9(8): 1878-1880 doi: 10.3748/wjg.v9.i8.1878
|
| 127 |
Rafail I. Kushak, Timothy M. Buie, Katherine F. Murray, David S. Newburg, Ceng Chen, Eirini Nestoridi, Harland S. Winter. Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms. Journal of Pediatric Gastroenterology and Nutrition 2016; 62(5) doi: 10.1097/MPG.0000000000001174
|
| 128 |
J K Moore, S West, S Kelly, G Robins. OC-090 To determine the negative predictive value of faecal calprotectin in predicting future organic gastrointestinal disease. Small bowel & nutrition free papers 2015; doi: 10.1136/gut.2009.208991l
|
| 129 |
Levent Filik, Ulku Dagli, Aysel Ulker. C-reactive protein and monitoring the activity of Crohn’s disease. Advances in Therapy 2006; 23(4) doi: 10.1007/BF02850054
|
| 130 |
Linn A. Brunborg, Tor M. Madland, Ragna A. Lind, Gülen Arslan, Arnold Berstad, Livar Frøyland. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: A pilot study comparing seal oil and cod liver oil. Clinical Nutrition 2008; 27(4) doi: 10.1016/j.clnu.2008.01.017
|